Skip to content | Change text size

BMC1021

Introduction to Medicinal Chemistry ( 6 points, SCA Band 2, 0.125 EFTSL)

Undergraduate
(PHA)

Leader: Dr Ian Crosby

Offered:
Clayton Second semester 2006 (Day)

Synopsis: This subject introduces the participant to drugs and why we need new ones? Topics to be covered will include a historical perspective of drug discovery; an introduction to drug action, sources of drugs, drug discovery by design, protein-drug interactions, drug solubility membranes,pharmacokinetics, drug stability, drugs and metal chelation, metalloproteins, chelation therapy.

Objectives: 1. Appreciate the relative scale of organisms, organs, cells, bacteria, viruses, proteins, drugs, atoms. 2. Give simple definitions of drug, activity, potency, efficacy, side-effect, ligand, macromolecule, agonist, antagonist, substrate, inhibitor, ED50, LD50, therapeutic index, lead compound, analogue compound, dosage form, active consituent, excipient, route of administration, prodrug, pharmacophore 3. Briefly discuss, in simple terms, enzyme action and methods of enzyme inhibition 4. Briefly discuss, in simple terms, the three main families of membrane bound receptors and the effect of ligand binding. 5. Briefly discuss other ways drugs can act (on carrier proteins, on structural proteins, on nucleic acid binding, on lipid function, on carbohydrate binding) 6. Briefly discuss molecular shape, structural rigidity, structural flexibility, configuration, molecular size 7. Outline the capabilities of molecular modelling and its limitations 8. Describe factors affecting drug receptor interactions down to the functional group level 9. Understand the importance of solvation/desolvation in drug binding 10. Understanding of solutions in terms of solubilisation of drugs 11. Identify where and how lipids contribute to solubility of drugs 12. Identify functional groups that can direct or improve solubility 13. Understand how surfactants or micelles aid water solubility 14. Define the partition coefficient as applied to a biological system 15. Identify components of a biological membrane 16. Understand the roles of different membrane proteins 17. Understand the effect of the blood-brain barrier in drug transport 18. Define how drugs act at membranes and cell walls 19. Define the factors that quantify the response of a drug 20. Understand the difference between chemical and metabolic stability 21. Be able to apply kinetic models to determine drug elimination 22. Factors that require consideration in drug design for targeting tissues 23. Define the term ligand, and understand how ligands combine with metal ions to form complexes. 24. Understand how drug action is affected by metal chelation 25. Factors that contribute to complex stability 26. Understand the principles of HASB 27. Define some of the roles of metalloproteins in biological processes 28. Outline the application of chelating agents in diseases 29. Have an appreciation of pharmaceutical industry in an Australian context

Assessment: End of semester exam: 60%; Two MCQ tutorial tests: 10%; Tutorial assignment:10%; Practical class: 20%